You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Sanofi India slips as Q1 PAT declines 8% to 85 cr

Business Finance

Capital Market 

Sanofi India fell 1.01% to Rs 7400.65 after net profit fell 8.1% to Rs 85.40 crore on 9.4% increase in net sales to Rs 784.50 crore in Q1 March 2020 over Q1 March 2019.

Total expenses in the first quarter of the calendar year 2020 rose 16.8% on a year-on-year (YoY) basis to Rs 658.20 crore, due to higher raw material costs (up 13.9% YoY) and higher employee expenses (up 16.1% YoY).

Profit before tax stood at Rs 134.60 crore in Q1 CY20, down by 10.7% from Rs 150.70 crore in Q1 CY19. Current tax expenses fell 9.32% to Rs 53.50 crore in Q1 CY20 over Q1 CY19.

"COVID-19 situation has not had any material effect on the company's financial results for the quarter ended March 31, 2020. The effect of COVID-19 situation on the operations and financial results of the company for the financial year ending 31 December 2020 cannot be estimated at this stage", the company said.

Sanofi India manufactures pharmaceuticals and chemicals. The company has portfolio of vaccines, major biological products, generics medicines, consumer healthcare, animal healthcare, and has a presence in both traditional and emerging markets.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, May 19 2020. 15:21 IST